Long-term analysis in acute coronary syndrome: Are there any differences in morbidity and mortality?;Análise em longo prazo na síndrome coronariana aguda: Existem diferenças na morbimortalidade?

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 6, 2010, Pages 705-712

  De Aguiar, Adolfo Alexandre Farah ^a   Mourilhe Rocha, Ricardo ^a   Esporcatte, Roberto ^a   Amorim, Liana Correa ^a   Tura, Bernardo Rangel ^a   De Albuquerque, Denilson Campos ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Acute coronary syndrome mortality trends; Drug evaluation; Heart failure; Morbidity

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ACCURACY; ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DEMOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT SELECTION; PREDICTION; PROGNOSIS; ST SEGMENT ELEVATION; THORAX PAIN;

ACUTE CORONARY SYNDROME; AGE FACTORS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CREATININE; FEMALE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; TIME FACTORS;

EID: 79551578906     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000157     Document Type: Article

References (25)

1. Gaziano JM. Global burden of cardiovascular disease. In: Braunwald E, Libby P, Bonow RO, Mann DL, Zipes DP (eds). Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia: Saunders Elsevier; 2008. p. 1-22.
2. Ministério da Saúde. Secretaria Executiva. Datasus. Informações de Saúde. Taxa de mortalidade específica por doenças do aparelho circulatório. [Acesso 2009 ago 10]. Disponível em: http://www.tabanet.datasus.gov.br
3. Antman EM. General hospital management. In: Julian D, Braunwald E (eds). Management of acute myocardial infarction. London: W.B. Saunders; 1994. p. 29-70.
4. Ganz P, Ganz W. Coronary blood flow and myocardial ischemia. In: Braunwald E, Zipes DP, Libby P (eds). Braunwald's heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: Saunders Elsevier; 2001. p. 1118-44.
5. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure. JAMA. 2005; 293 (5): 572-80.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325 (5): 293-302.
7. Albuquerque DC, Rocha RM, Esporcatte R. Terapia antiadrenérgica na insuficiência cardíaca. Clínica Médica. 2002; 2 (2): 331-40.
8. The Cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet. 1999; 353 (9146): 9-13. (Pubitemid 29037695)
9. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001; 344 (22): 1651-8.
10. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomised controlled trial. Lancet. 2003; 362 (9377): 7-13.
11. Jafri SM. The effects of beta blockers on morbidity and mortality in heart failure. Heart Fail Rev. 2004; 9 (2): 115-21.
12. Packer M, Bristow MR, Cohn JN, Collucci WS, Fowler MB, Gilbert EM, et al. for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996; 334 (21): 1349-55.
13. Orso F, Baldasseroni S, Fabbri G, Gonzini L, Lucci D, D'Ambrosi C, et al. Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian survey on acute heart failure. Eur J Heart Fail. 2009; 11 (1): 77-84.
14. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized intervention trial in congestive heart failure (MERIT-HF). MERITHF Study Group. JAMA. 2000; 283 (10): 1295-302.
15. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure:results of the Cooperative North Scandinavian enalapril survival study (CONSENSUS). N Engl J Med. 1987; 316 (23): 1429-35.
16. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325 (5): 303-10.
17. Rassi S, Barreto ACP, Porto CC, Pereira CR, Calaça BW, Rassi DC. Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas. Arq Bras Cardiol. 2005; 84 (4): 309-13.
18. Alla F, Briançon S, Juillière Y, Mertes PM, Villemot JP, Zannad F. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J. 2000;139 (5): 895-904.
19. Zannad F, Briançon S, Juillière Y, Mertes PM, Villemot JP, Alla F. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'insuffisance cardiaque avancée en Lorraine. J Am Coll Cardiol. 1999; 33 (3): 734-42.
20. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B, for the POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006; 27 (10): 1216-22.
21. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008; 168 (8): 847-54.
22. Rocha RM, Albuquerque DC, Aguiar AA, Oliveira AP, Esporcatte R. Influence of gender, aging and left ventricular systolic dysfunction in morbidity and mortality of patients with acute coronary syndromes [abstract]. In: 11th Annual Scientific Meeting of Heart Failure Society of America; 2007 Sept. 16-19. Proceedings. Seattle, USA. J Card Fail. 2007; 13: 164.
23. Albuquerque DC, Aguiar AFA, Rocha RM, Corrêa LA, Tura BR, Esporcatte R. Preditores de longo prazo de morbimortalidade e marcadores de sobrevida de pacientes com síndrome coronariana aguda num hospital terciário. [Abstract]. Arq Bras Cardiol. 2009; 93 (supl 1): 191.
24. Rich MW. Heart failure in older adults. Med Clin North Am. 2006; 90 (5): 863-85.
25. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson C, Coats AJ, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J. 2002; 23 (11): 877-85.